PureTech Health News
Press Releases
Press releases 2017-09-25
Tunable Hydrogel for Local GI Modulation
PureTech Health’s Gelesis Reports Significant Weight Loss with Excellent Safety Profile in Pivotal Study with Gelesis100

PureTech Health plc ("PureTech", LSE: PRTC), an advanced, clinical-stage biopharmaceutical company, is pleased to note that Gelesis, an affiliate of PureTech Health, today announced topline results from the pivotal weight loss study (GLOW) of one of its product candidates, Gelesis100.

Continue
Press releases 2017-09-20
Vocal Biomarkers
PureTech Health Notes US Patent Issuance Broadly Covering Methods of Assessing Mental and Physical Condition from Human Speech
PureTech Health plc (“PureTech Health” or the “Company”, LSE: PRTC), an advanced, clinical-stage biopharmaceutical company, is pleased to note that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 9,763,617 for its Sonde vocal biomarkers programme.
Continue
Press releases 2017-09-19
Lymphocyte Trafficking - Calix
PureTech Health Exclusively Licenses Novel Milk-Derived Exosome Technology for Oral Administration of Biologics, Nucleic Acids, and Complex Small Molecules

PureTech Health plc (“PureTech Health” or the “Company”, LSE: PRTC), an advanced, clinical-stage biopharmaceutical company, today announced an exclusive licensing agreement with 3P Biotechnologies, Inc., via University of Louisville, for an exosome-based technology (Calix) for the oral administration of biologics, nucleic acids, and complex small molecules.

Continue
Press releases 2017-08-29
Lymphatic Targeting
PureTech Health Exclusively Licenses Glyph Technology from Monash University to Harness Lymphatic Biology

Novel approach designed to enable oral administration of medicines that traffic via the lymphatic system and selectively target the lymph nodes.

Full article

Press releases 2017-08-15
PureTech Health Notice of Half-Yearly Results
Press releases 2017-07-13
Inflammation-Targeting Hydrogel
PureTech Health Presents Data Supporting Treatment Approach for Interstitial Cystitis/Bladder Pain Syndrome Based on Novel Alivio Inflammation-Targeting Technology
Press releases 2017-07-12
Tunable Hydrogel for Local GI Modulation
PureTech Health’s Gelesis Announces Last Patient Visit in the Pivotal Gelesis100 Weight-Loss Study
Press releases 2017-06-28
Cognitive Interference Processing
PureTech Health’s Akili Appoints Former Cubist CEO, Rob Perez, as Executive Chairman
Press releases 2017-05-30
Microbiome-Derived Immune Modulators
PureTech Health’s Vedanta Biosciences Granted U.S. Patent Broadly Covering Methods of Treatment with Therapeutics Based on Bacterial Spore Fractions of Microbiota Obtained From Human Donors
Press releases 2017-05-25
PureTech Health to Present at Jefferies 2017 Global Healthcare Conference

@PureTechH

Exploring the Brain Immune Gut Interface

Targeting serious diseases caused by dysfunctions in the brain-immune-gut axis

See Our Science